Procept Biorobotics Corp (PRCT)

Currency in USD
49.96
+1.45(+2.99%)
Closed·
Pre Market
50.75+0.79(+1.58%)
·

PRCT Earnings

Latest Release
May 02, 2025
EPS / Forecast
-0.45 / -0.4907
Revenue / Forecast
69.16M / 65.43M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.413--/76.12M----Free Sign Up
03/2025-0.45/-0.49169.16M/65.43M+8.29%+5.7%Free Sign Up
12/2024-0.35/-0.3468.24M/66.83M-2.94%+2.11%Free Sign Up
09/2024-0.4/-0.4958.37M/53.3M+18.37%+9.51%Free Sign Up
06/2024-0.5/-0.5253.3M/50.1M+3.85%+6.39%Free Sign Up
03/2024-0.51/-0.5544.5M/41.58M+7.27%+7.02%Free Sign Up
12/2023-0.54/-0.4443.6M/41.49M-22.73%+5.09%Free Sign Up
09/2023-0.51/-0.5335.1M/33.44M+3.77%+4.96%Free Sign Up
06/2023-0.56/-0.5733.1M/30.31M+1.75%+9.2%Free Sign Up
03/2023-0.63/-0.6324.4M/24.4M0%0%Free Sign Up

All numbers in USD

Procept Biorobotics Corp Earnings Call Summary for Q1/2025

  • Procept Biorobotics beats Q1 2025 EPS forecast with -$0.45 vs -$0.4907 expected; revenue reaches $69.2M, exceeding $65.43M estimate
  • Total revenue up 55% YoY; U.S. revenue grows 50% to $60.3M; gross margin improves 7.5 points to 63.9%
  • Full-year revenue guidance set at $323M, up 44% YoY; plans to sell 210 new robotic systems in 2025
  • Stock rises 0.92% in pre-market trading; analysts maintain strong buy consensus with 1.6 rating
  • Company expands internationally in UK and Japan; receives FDA IDEA approval for prostate cancer trial
Last Updated: 24/04/2025, 14:36
Read Full Transcript

FAQ

What Is Procept Biorobotics's Earnings Per Share (TTM)?

The Procept Biorobotics EPS (TTM) is -1.70.

When Is The Next Procept Biorobotics Earnings Date?

Procept Biorobotics will release its next earnings report on 29 Oct 2025.

What Is Procept Biorobotics’s Revenue Forecasts For Upcoming Quarters?

Procept Biorobotics’s revenue forecast is 76.12M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.